COMMUNIQUÉS West-GlobeNewswire

Saxenda® provides consistent weight loss and improvements in blood glucose control across BMI categories after three years of treatment

05/11/2018 - 00:23

Munich, Germany, 14 September 2016 - Results from a post hoc analysis of the three-year part of the phase 3a SCALE (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial show that people [...]

Victoza® lowered the progression of kidney damage in adults with type 2 diabetes at high CV risk

05/11/2018 - 00:22

Munich, Germany, 15 September 2016 - Novo Nordisk today announced that the progression of kidney damage was significantly lower with Victoza ® treatment vs placebo, as measured by urinary albumin creatinine ratio, both [...]

Semaglutide reduced major cardiovascular events by 26% in adults with type 2 diabetes at high cardiovascular risk

05/11/2018 - 00:18

Munich, Germany, 16 September 2016 - Novo Nordisk today announced that semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue administered once-weekly, significantly reduced the risk of the primary [...]

Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access and sustainability needs

02/11/2018 - 23:01

Decision follows FDA request for additional information to complement submission for biosimilar rituximab Sandoz stands behind safety, efficacy and quality of our biosimilar rituximab, which is already approved in EU, [...]

Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology

02/11/2018 - 22:16

Additional analysis from pivotal Phase III SOLAR-1 clinical trial studying investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) and fulvestrant in patients with PIK3CA-mutated HR+/HER2- advanced or [...]

XBiotech présente les développements du troisième trimestre 2018

02/11/2018 - 22:09

La société fournit une vue d'ensemble mise à jour, y compris de son flux clinique et de découverte, ainsi que d'autres initiatives d’entreprise AUSTIN, Texas, 02 nov. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT [...]

CORRECTED: NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings

02/11/2018 - 22:05

AMES, Iowa, Nov. 02, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline yesterday by NewLink Genetics Corporation (NASDAQ:NLNK), the balance statement included in the press release was incorrect. The [...]

FibroGen to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018

02/11/2018 - 22:02

Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT) SAN FRANCISCO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a biopharmaceutical company, today announced that it will [...]

Bespoke Extracts Appoints Niquana Noel as New Chief Executive Officer

02/11/2018 - 21:54

SUNNY ISLES, Fla., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, today announced that the Company’s Board of Directors has [...]

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018

02/11/2018 - 21:05

RANCHO CUCAMONGA, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its Third quarter of 2018 ended September 30, 2018, after [...]

Resverlogix Closes $13.5 Million Private Placement

02/11/2018 - 21:05

CALGARY, Alberta, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has closed a private placement of approximately 4.5 million equity units at a price of [...]

Aclaris Therapeutics to Attend Upcoming Investor Conferences

02/11/2018 - 21:01

WAYNE, Pa., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

OPEN CALL: #MyHhStory AUDIO Project

02/11/2018 - 19:39

Excessive Sweating Story Will Be Selected for Professional Recording & Archived in Library of Congress CENTER VALLEY, Pa., Nov. 02, 2018 (GLOBE NEWSWIRE) -- When someone suffers from hyperhidrosis (Hh), or excessive [...]

Golden Leaf Holdings Reschedules Date of Conference Call for Review of Its Third Quarter 2018 Results

02/11/2018 - 19:39

PORTLAND, Ore., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]

Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018

02/11/2018 - 19:30

HOLLISTON, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting its new [...]

Jounce Therapeutics to Present Two Posters from the JTX-2011 Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

02/11/2018 - 18:48

CAMBRIDGE, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

Trevena Receives Complete Response Letter for Oliceridine from FDA

02/11/2018 - 18:42

Company to host conference call and webcast on November 5 th CHESTERBROOK, Pa., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) today announced the Company has received a Complete Response Letter (CRL) [...]

U.S. FDA Approves UDENYCA™ (pegfilgrastim-cbqv)

02/11/2018 - 18:41

REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ: CHRS), today announced that the U.S. Food and Drug Administration (FDA) has approved UDENYCA™ (pegfilgrastim-cbqv), the first [...]

N.M. Provider Wins Favorable Ruling in Plant Count Lawsuit

02/11/2018 - 18:28

Ultra Health is the first cannabis provider to win a lawsuit over production regulations SANTA FE, N.M., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Nicole Sena, a medical cannabis caregiver to her infant daughter with a rare [...]